Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Perrigo Company (PRGO) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 11,154,500
  • Shares Outstanding, K 143,280
  • Annual Sales, $ 2,770 M
  • Annual Income, $ 6 M
  • 36-Month Beta 0.72
  • Price/Sales 1.98
  • Price/Book 1.29

Price Performance

See More
Period Period Low Period High Performance
1-Month
74.90 +1.99%
on 01/18/17
87.48 -12.68%
on 01/04/17
-8.16 (-9.65%)
since 12/19/16
3-Month
74.90 +1.99%
on 01/18/17
92.64 -17.54%
on 10/21/16
-11.79 (-13.37%)
since 10/19/16
52-Week
74.90 +1.99%
on 01/18/17
152.36 -49.86%
on 01/22/16
-70.11 (-47.86%)
since 01/19/16

Most Recent Stories

More News
Is Perrigo Company (PRGO) a Great Stock for Value Investors?

Let's delve into the value metrics of Perrigo Company (PRGO) and determine whether it is a good value investment right now.

Perrigo Updates Segment Reporting Structure

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has changed its reporting segments to better align with the Company's organizational structure. Beginning with the fourth quarter of calendar...

TLC Therapeutics, LLC Announces Multi-Product Licensing and Manufacturing Agreement with Rosemont Pharmaceuticals

TLC Therapeutics, LLC, a Baltimore-based pharmaceutical company, announces the execution of an exclusive, multi-product licensing and manufacturing agreement with Rosemont Pharmaceuticals, an UK-based...

Custopharm Acquires Two ANDA Pharmaceutical Products From Perrigo

Custopharm, Inc., a U.S. leader in generic injectable products, announced today that it has acquired two paragraph IV abbreviated new drug application (ANDA) products from Perrigo Company plc.

Perrigo to Present at the J.P. Morgan Global Healthcare Conference

Perrigo Company plc (NYSE: PRGO; TASE) today announced that CEO John T. Hendrickson will present at the J.P. Morgan Global Healthcare Conference at 11:00 AM EST on Tuesday, January 10, 2017 at the Westin...

Research and Markets - World Clinical Nutrition Products (Infant, Parenteral and Enteral Foods) Market 2016-2022 Featuring Hospira, Nestle, and Perrigo

Research and Markets has announced the addition of the "The World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral Foods), 7th Edition" report to their offering.

Perrigo Announces FDA Approvals For The Store Brand OTC Equivalents To Nicorette® White Ice Mint® Gum

Perrigo Company plc (NYSE: PRGO; TASE) today announced it has received approvals from the U.S. Food and Drug Administration for Abbreviated New Drug Applications referencing GlaxoSmithKline's Nicorette®...

Perrigo Announces Portfolio Review Developments And Intention To Restructure Branded Consumer Healthcare's Belgium Business

Perrigo Company plc (NYSE: PRGO; TASE) today announced its intention to restructure the Branded Consumer Healthcare's ("BCH") Omega Pharma Belgium business (which includes Omega Pharma Belgium NV, Etixx...

Research Reports Initiation on Healthcare Stocks -- Perrigo, Pacira Pharma, Supernus Pharma, and PerkinElmer

This morning, Stock-Callers.com has lined up the following healthcare stocks for assessment following a positive Monday's session where gains were broad based as all nine sectors ended the session in green:...

Stock Market News for November 10, 2016

Benchmarks finished higher on Wednesday as investors embraced the election of Republican Donald Trump as the president of the United States

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United...

See More

Support & Resistance

2nd Resistance Point 78.37
1st Resistance Point 77.41
Last Price 76.32
1st Support Level 75.20
2nd Support Level 73.95

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.